Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KINDRED CBD
- Development stage
- Unknown
- Lead developer
- Medigrowth Australia
- Modality
- Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
KINDRED CBD is a plant-based cannabinoid product developed by Medigrowth under its KINDRED brand, specifically formulated for the veterinary and pet wellness market. The product contains cannabidiol (CBD) and is marketed for the management of anxiety, chronic pain, and osteoarthritis in pets. CBD interacts with the endocannabinoid system, primarily acting as a non-competitive negative allosteric modulator of CB1 and CB2 receptors, and as an agonist at 5-HT1A and TRPV1 receptors. These interactions contribute to its anxiolytic, analgesic, and anti-inflammatory properties. It is currently available as a commercial product in the Australian market.
- Brand names
- KINDREDKINDRED CBD
- Other names
- Medigrow KINDREDMedigrowth KINDRED CBD
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))CNR1 (Cannabinoid receptor 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on KINDRED CBD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KINDRED CBD.